HTFL · Heartflow, Inc.
Market Cap
$4.18B
Shares
86.95M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$176.03M
+39.9%
FY2025
Net Income
-$116.79M
-21.1%
FY2025
Gross Margin
76.8%
+1.7pp
FY2025
Operating Margin
-36.39%
+12.3pp
FY2025
Diluted EPS
-$3.17
+82.4%
FY2025
Operating Cash Flow
-$54.02M
+21.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| $246M – $250M | $212.07M | $176.03M | $125.81M | $87.17M | |
| — | $42.24M | $40.84M | $31.36M | $29.12M | |
| — | $169.83M | $135.2M | $94.45M | $58.05M | |
| — | — | 76.8% | 75.07% | 66.59% | |
| — | $83.84M | $64.92M | $43.52M | $35.85M | |
| — | — | $39.49M | $30.79M | $31.79M | |
| — | $158.76M | $134.35M | $112.15M | $95.11M | |
| — | $5.32M | $5.44M | $5.36M | $4.74M | |
| — | $250.09M | $199.26M | $155.67M | $130.97M | |
| — | -$80.25M | -$64.07M | -$61.22M | -$72.91M | |
| — | — | -36.39% | -48.66% | -83.64% | |
| — | -$74.94M | -$58.63M | -$55.86M | -$68.17M | |
| — | $3.46M | $15.17M | $22.77M | $24.69M | |
| — | $9.13M | $5.54M | $4.07M | $5.46M | |
| — | -$38.21M | -$52.8M | -$35.15M | -$22.19M | |
| — | -$118.46M | -$116.87M | -$96.37M | -$95.11M | |
| — | — | -$76K | $53K | $547K | |
| — | -$118.37M | -$116.79M | -$96.43M | -$95.66M | |
| — | — | -66.35% | -76.65% | -109.73% | |
| — | — | -$116.79M | -$96.43M | -$123.69M | |
| — | -$118.55M | -$116.44M | -$96.7M | -$96.16M | |
| USD/shares | — | $3.04 | -$3.17 | -$17.98 | -$25.32 |
| USD/shares | — | $3.04 | -$3.17 | -$17.98 | -$25.32 |
| shares | — | — | 36.85M | 5.36M | 4.89M |
| shares | — | — | 36.85M | 5.36M | 4.89M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Peer median 39.77×
Peer medians compare against the 21 similar-size Health Information Services companies (of 45 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| United States | $162,733,000 | $115,036,000 | $77,725,000 |
| Non Us | $13,301,000 | $10,772,000 | $9,449,000 |
Key facts
CIK
1464521
CUSIP
42238D107
13F (30d)
170 filings
168 filers
Visit website
Investor relations